Home » Products » Empagliflozin 25mg Tablets | GMP Manufacturer & Supplier | Sinophare
Product Description
| Product Name | Empagliflozin Tablets (Empagliflozin 25mg Oral Tablets) |
| Specification | Each tablet contains: Empagliflozin 25mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Empagliflozin |
| Pharmacological Class | Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor (Antidiabetic Agent) |
| Route of Administration | Oral administration (swallowed whole with water; take at approximately the same time each morning, with or without food). |
| Packaging | Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Shelf Life | 36 months (unopened) |
Product Overview
Empagliflozin Tablets is an oral preparation containing Empagliflozin 25mg per film-coated tablet. Empagliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease, as well as to slow the progression of chronic kidney disease. SGLT2 inhibitors work by a mechanism that is independent of insulin secretion, which differentiates them from other classes of antidiabetic medications.
